miRNAs in inflammatory skin diseases and their clinical implications

References

• Ambros V, Lee RC, Lavanway A, et al. MicroRNAs and other tiny endogenous RNAs in C. elegans. Curr Biol 2003;13:807-18
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116(2):281-97
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009;136(2):215-33
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843-54
   PubMed Web of Science ®Google Scholar
• Reinhart BJ, Slack FJ, Basson M, et al. The 21-nucleotide let-7 RNA regulates developmental timing in caenorhabditis elegans. Nature 2000;403(6772):901-6
   PubMed Web of Science ®Google Scholar
• Pasquinelli AE, Reinhart BJ, Slack F, et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000;408(6808):86-9
   PubMed Web of Science ®Google Scholar
• miRBase. Available from: www.miRBase.org
   Google Scholar
• Friedman RC, Farh KK, Burge CB, et al. Most mammalian mRNAs are conserved targets of miRNAs. Genome Res 2009;19:92-105
   PubMed Web of Science ®Google Scholar
• Finnegan EF, Pasquinelli AE. MicroRNA biogenesis: regulating the regulators. Crit Rev Biochem Mol Biol 2013;48(1):51-68
   PubMed Web of Science ®Google Scholar
• Lee Y, Kim M, Han J, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J 2004;23:4051-60
   PubMed Web of Science ®Google Scholar
• Lund E, Güttinger S, Calado A, et al. Nuclear export of microRNA precursors. Science 2004;303:95-8
   PubMed Web of Science ®Google Scholar
• Hutvanger G, Zamore PD. A microRNA in a multiple turnover RNAi enzyme complex. Science 2002;297:2056-60
   PubMedGoogle Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20
   PubMed Web of Science ®Google Scholar
• Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011;12:99-110
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyy SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102-14
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006;11(4):441-50
   PubMed Web of Science ®Google Scholar
• Baek D, Villén J, Shin C, et al. The impact of microRNAs on protein output. Nature 2008;455:64-71
   PubMed Web of Science ®Google Scholar
• Vlachos IS, Hatzigeorgiou AG. Online resources for miRNA analysis. Clin Biochem 2013;46:879-900
   PubMedGoogle Scholar
• Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010;465(7301):1033-8
   PubMed Web of Science ®Google Scholar
• Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007;318:1931-4
   PubMed Web of Science ®Google Scholar
• Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5’ UTR as in the 3’ UTR. Proc Natl Acad Sci USA 2007;104(23):9667-72
   PubMed Web of Science ®Google Scholar
• Kong YW, Ferland-McCollough D, Jackson TJ, et al. MicroRNAs in cancer management. Lancet Oncol 2012;13(6):e249-58
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Rao DS, Chaudhuri AA, et al. Physiological and pathological roles for microRNA in the immune system. Nat Rev Immunol 2010;10:111-22
   PubMed Web of Science ®Google Scholar
• Elmén J, Lindow M, Schütz S, et al. LNA-mediated microRNA silencing in non-human primates. Nature 2008;452(7189):896-9
   PubMed Web of Science ®Google Scholar
• Lanford RE, Hildebrandt-Eriksen ES, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis c virus infection. Science 2010;327:198-201
   PubMed Web of Science ®Google Scholar
• Safety study of SPC3649 in healthy men. Available from: https://clinicaltrials.gov/ct2/show/NCT00688012
   Google Scholar
• SPC3649 multiple dose study in healthy volunteers. Available from: https://clinicaltrials.gov/ct2/show/NCT00979927
   Google Scholar
• Multiple ascending dose study of miravirsen in treatment-naïve chronic hepatitis c subjects. Available from: https://clinicaltrials.gov/ct2/show/NCT01200420
   Google Scholar
• Lindow M, Kauppinen S. Discovering the first microRNA-targeted drug. J Cell Biol 2012;199(3):407-12
   PubMed Web of Science ®Google Scholar
• Van Rooij E, Kauppinen S. Development of microRNA therapeutics is coming of age. EMBO Mol Med 2014;6(7):851-64
   PubMed Web of Science ®Google Scholar
• Bouchie A. First microRNA mimic enters clinic. Nat Biotechnol 2013;31:577
   PubMed Web of Science ®Google Scholar
• Andl T, Murchison EP, Liu F, et al. The miRNA-processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles. Curr Biol 2006;16:1041-9
   PubMed Web of Science ®Google Scholar
• Yi R, O’Carroll D, Pasolli HA, et al. Morphogenesis in skin is governed by discrete sets of differentially expressed miRNAs. Nat Genet 2006;38:356-62
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2007;2(7):e610
   PubMed Web of Science ®Google Scholar
• Yi R, Poy MN, Stoffel M, et al. A skin microRNA promotes differentiation by repressing ‘stemness’. Nature 2008;452(7184):225-9
   PubMed Web of Science ®Google Scholar
• Lena AM, Shalom-Feuerstein R, Rivetti di Val Cervo P, et al. miR-203 represses ‘stemness’ by repressing DeltaNp63. Cell Death Differ 2008;15(7):1187-95
   PubMed Web of Science ®Google Scholar
• Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol 2014;32:227-55
   PubMed Web of Science ®Google Scholar
• Zibert JR, Løvendorf MB, Litman T, et al. MicroRNAs and potential target interactions in psoriasis. J Dermatol Sci 2010;58(3):177-85
   PubMed Web of Science ®Google Scholar
• Løvendorf MB, Zibert JR, Hagedorn PH, et al. Comparison of microRNA expression using different preservation methods of matched psoriatic skin samples. Exp Dermatol 2012;21:299-319
   PubMedGoogle Scholar
• Joyce CE, Zhou X, Xia J, et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet 2011;20(20):4025-40
   PubMed Web of Science ®Google Scholar
• Xia J, Joyce CE, Bowcock AM, et al. Noncanonical microRNAs and endogenous siRNAs in normal and psoriatic human skin. Hum Mol Genet 2013;22(4):737-48
   PubMedGoogle Scholar
• Curtale G, Citarella F. Dynamic nature of noncoding RNA regulation of adaptive immune responses. Int J Mol Sci 2013;14:17347-77
   PubMedGoogle Scholar
• Lerman G, Avivi C, Mardoukh C, et al. MiRNA expression in psoriatic skin: reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS One 2011;6(6):e20916
   PubMed Web of Science ®Google Scholar
• Xu N, Brodin P, Wei T, et al. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol 2011;131:1521-9
   PubMed Web of Science ®Google Scholar
• Xu N, Meisgen F, Butler LM, et al. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol 2013;190(2):678-88
   PubMed Web of Science ®Google Scholar
• Løvendorf MB, Mitsui H, Zibert JR, et al. Laser capture microdissection followed by next-generation sequencing identifies disease-related microRNAs in psoriatic lesions that reflect systemic microRNA changes in psoriasis. Exp Dermatol 2014. [Epub ahead of print]
   Google Scholar
• Rossi RL, Rossetti G, Wenandy L, et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 2011;12:796-803
   Google Scholar
• Allantaz F, Cheng DT, Bergauer T, et al. Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One 2012;7:e29979
   PubMed Web of Science ®Google Scholar
• Mitsui H, Suárez-Fariñas M, Belkin DA, et al. Combined use of laser capture microdissection and cDNA microarray analysis identifies locally expressed disease-related genes in focal regions of psoriasis vulgaris skin lesions. J Invest Dermatol 2012;132:1615-26
   PubMed Web of Science ®Google Scholar
• Zaba LC, Cardinale I, Gilleaudeau P, et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 2007;204:3183-94
   PubMed Web of Science ®Google Scholar
• Turner ML, Schnorfeil FM, Brocker T. MicroRNAs regulate dendritic cell differentiation and function. J Immunol 2011;187:3911-17
   PubMed Web of Science ®Google Scholar
• Wang S, Olson EN. AngiomiRs – key regulators of angiogenesis. Curr Opin Genet Dev 2009;19:205-11
   PubMed Web of Science ®Google Scholar
• Zhao M, Wang LT, Liang GP, et al. Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4(+) T cells of psoriasis vulgaris. Clin Immunol 2014;150(1):22-30
   PubMed Web of Science ®Google Scholar
• Løvendorf MB, Zibert JR, Gyldenløve M, et al. MicroRNA-223 and miR-143 are important systemic biomarkers for disease activity in psoriasis. J Dermatol Sci 2014;75(2):133-9
   PubMed Web of Science ®Google Scholar
• Lønnberg AS, Skov L, Skytthe A, et al. Heritability of psoriasis in a large twin sample. Br J Dermatol 2013;169(2):412-16
   PubMedGoogle Scholar
• Tsoi LC, Spain SL, Knight J, et al. Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012;44(12):1341-8
   PubMed Web of Science ®Google Scholar
• Wu LS, Li FF, Sun LD, et al. A miRNA-492 binding-site polymorphism in BSG (basigin) confers risk to psoriasis in central south Chinese population. Hum Genet 2011;130(6):749-59
   PubMedGoogle Scholar
• Zhang W, Yi X, Guo S, et al. A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study. J Cell Mol Med 2014;18(11):2225-34
   PubMed Web of Science ®Google Scholar
• Guttman-Yassky E, Dhingra N, Leung DYM. New era of biological therapeutics in atopic dermatitis. Expert Opin Biol Ther 2013;13(4):549-61
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Janson P, Majuri ML, et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol 2010;126(3):581-9
   PubMed Web of Science ®Google Scholar
• Rebane A, Runnel T, Aab A, et al. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. J Allergy Clin Immunol 2014;134(4):836-47. e11
   PubMed Web of Science ®Google Scholar
• Vennegaard MT, Bonefeld CM, Hagedorn PH, et al. Allergic contact dermatitis induces upregulation of identical microRNAs in humans and mice. Contact Dermat 2012;67(5):298-305
   PubMedGoogle Scholar
• Gulati N, Løvendorf MB, Zibert JR, et al. Unique miRNAs appear at different times during the course of a delayed-type hypersensitivity (DTH) reaction in human skin. Abstr. # 50 Annual meeting, Society Invest Dermatol (SID), Albuquerque, New Mexico, US; May 2014
   Google Scholar
• Liu A, Tetzlaff MT, Vanbelle P, et al. MicroRNA Expression profiling outperforms mRNA expression profiling in formalin-fixed paraffin-embedded tissues. Int. J Clin Exp Pathol 2009;2:519-27
   PubMed Web of Science ®Google Scholar
• Glud M, Klausen M, Gniadecki R, et al. MicroRNA expression in melanocytic nevi: the usefulness of formalin-fixed, paraffin-embedded material for miRNA microarray profiling. J Invest Dermatol 2009;129:1219-24
   PubMed Web of Science ®Google Scholar
• Ralfkiaer U, Hagedorn PH, Bangsgaard N, et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011;118(22):5891-900
   PubMed Web of Science ®Google Scholar
• Marstrand T, Ahler CB, Ralfkiaer U, et al. Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas. Leuk Lymphoma 2014;55(4):957-8
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-1006
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-18
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010;101:2087-92
   PubMed Web of Science ®Google Scholar
• Reid G, Kirschner MB, Zandwijk NV. Circulating microRNAs: association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 2011;80:193-208
   PubMed Web of Science ®Google Scholar
• PubMed. Available from: www.PubMed.gov
   Google Scholar
• Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res 2012;5(3):492-7
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9(6):654-9
   PubMed Web of Science ®Google Scholar
• Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009;2(100):ra81
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13(4):423-33
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011;108(12):5003-8
   PubMed Web of Science ®Google Scholar
• Oyama R, Jinnin M, Kakimoto A, et al. Circulating miRNA associated with TNF-a signaling pathway in Patients with plaque psoriasis. J Dermatol Sci 2011;61:206-17
   PubMedGoogle Scholar
• Ichihara A, Jinnin M, Oyama R, et al. Increased serum levels of miR-1266 in patients with psoriasis Vulgaris. Eur J Dermatol 2012;22:68-71
   PubMedGoogle Scholar
• Pivarcsi A, Meisgen F, Xu N, et al. Changes in the level of serum miRNAs in patients with psoriasis after antitumour necrosis factor-a therapy. British J Dermatol 2013;169:563-70
   PubMed Web of Science ®Google Scholar
• Garciá-Rodríguez S, Arias-Santiago S, Orgaz-Molina J, et al. Abnormal levels of expression of plasma microRNA-33 in patients with psoriasis. Actas Dermosifiliogr 2014;105(5):497-503
   PubMedGoogle Scholar
• Guinea-Viniegra J, Jiménez M, Schonthaler HB, et al. Targeting miR-21 to treat psoriasis. Sci Transl Med 2014;6(225):225re1
   PubMed Web of Science ®Google Scholar
• Smith FJ, Hickerson RP, Sayers JM, et al. Development of therapeutic siRNAs for pachyonychia congenita. J Invest Dermatol 2008;128(1):50-8
   PubMedGoogle Scholar
• Hickerson RP, Smith FJ, Reeves RE, et al. Single-nucleotide-specific siRNA targeting in a dominant-negative skin model. J Invest Dermatol 2008;128(3):594-605
   PubMedGoogle Scholar
• Leachman SA, Hickerson RP, Schwartz ME, et al. First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 2010;18(2):442-6
   PubMed Web of Science ®Google Scholar
• Yi X, Zhao G, Zhang H, et al. MITF-siRNA formulation is a safe and effective therapy for human melasma. Mol Ther 2011;19(2):362-71
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Lovén J, Xu N, et al. MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. Oncogenesis 2012;1:e3
   PubMed Web of Science ®Google Scholar
• Sun V, Zhou WB, Majid S, et al. MicroRNA-mediated regulation of melanoma. Br J Dermatol 2014;171(2):234-41
   PubMed Web of Science ®Google Scholar
• Liew CC, Ma J, Tang HC, et al. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006;147(3):126-32
   PubMed Web of Science ®Google Scholar
• McDonald JS, Milosevic D, Reddi HV, et al. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 2011;57(6):833-40
   PubMed Web of Science ®Google Scholar
• Cortez MA, Bueso-Ramos C, Ferdin J, et al. MicroRNAs in body fluids – the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011;8:467-77
   PubMed Web of Science ®Google Scholar
• Boele J, Persson H, Shin JW, et al. PAPD5-mediated 3’ adenylation and subsequent degradation of miR-21 is disrupted in proliferative disease. Proc Natl Acad Sci USA 2014;111(31):11467-72
   PubMed Web of Science ®Google Scholar
• Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature 2012;489:101-8
   PubMed Web of Science ®Google Scholar
• Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 2012;22:1775-89
   PubMed Web of Science ®Google Scholar